Table 4.

MBF in CAC and non-CAC myocardial territory

	MBF at rest	MBF during CPT	MBF during adenosine
Whole study group
CAC territory	0.69±0.24	0.81±0.23	1.82±0.50
Non-CAC territory	0.74±0.23*	0.81±0.22	1.95±0.51*
CON
CAC territory	0.61 ±0.15	0.81±0.22	1.96±0.64
Non-CAC territory	0.65±0.19*	0.77±0.31	2.10±0.58
DM
CAC territory	0.75±0.27	0.81±0.24	1.71 ±0.33
Non-CAC territory	0.80±0.24*	0.83±0.23	1.83±0.44
NDM
CAC territory	0.61 ±0.13	0.73±0.19	1.76±0.34
Non-CAC territory	0.68±0.13*	0.77±0.13	1.98±0.48
HDM
CAC territory	0.97±0.29	0.91±0.25	1.64±0.32
Non-CAC territory	0.99±0.23	0.91±0.30	1.61 ±0.25

Paired analysis of the vascular territory of the LAD, LCx and RCA CAC coronary artery calcification, CON controls, NDM normotensive diabetes mellitus, HDM hypertensive diabetes mellitus

^*p<0.02 vs. CAC territory